Gene Therapy for Wet AMD Shows Promise

Charles C. Wykoff, MD, PhD, FASRS, FACS

Show Description +

Dr. Wykoff discusses Ixo-vec (Adverum), a gene therapy for wet AMD currently under investigation in the phase 2 LUNA trial.

Posted: 7/25/2024

Keywords:

retina-meeting-recap

•

Ixo-vec

•

Adverum

•

Gene Therapy

•

Clinical Trials

•

Wet AMD

•

Age-Related Macular Degeneration (AMD)

Up Next

Name: Gene Therapy for Wet AMD Shows Promise
Uploaded: 2024-07-25T20:14:53+00:00
Description: Dr. Wykoff discusses Ixo-vec (Adverum), a gene therapy for wet AMD currently under investigation in the phase 2 LUNA trial.

Using Retinal Imaging to Identify Alzheimer Biomarkers

Sruthi Arepalli, MD

The Effect of Vitrectomy on AMD Progression

Chase Ludwig, MD

Using AI to Track GA Treatment Response

Ursula M. Schmidt-Erfurth, MD

More on Faricimab for DME: Efficacy and Safety

Chirag Jhaveri, MD

96-Week Safety Data Revealed for 8 mg Aflibercept

Christina Y. Weng, MD, MBA

Exploring DME Outcomes Based on Baseline Vision

Diana V. Do, MD

The PDS: Technical Changes and Clinical Experiences

Dante J. Pieramici, MD

Pegcetacoplan in the Trials and the Real-World

David A. Eichenbaum, MD

An Update on AVD-104 for the Treatment of GA

Rishi P. Singh, MD

Gene Therapy for Wet AMD Shows Promise

Charles C. Wykoff, MD, PhD, FASRS, FACS

Back to All Videos

Gene Therapy for Wet AMD Shows Promise

Charles C. Wykoff, MD, PhD, FASRS, FACS

Dr. Wykoff discusses Ixo-vec (Adverum), a gene therapy for wet AMD currently under investigation in the phase 2 LUNA trial.

Posted: 7/25/2024

Keywords:

retina-meeting-recap

•

Ixo-vec

•

Adverum

•

Gene Therapy

•

Clinical Trials

•

Wet AMD

•

Age-Related Macular Degeneration (AMD)

Please log in to leave a comment.

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

Gene Therapy for Wet AMD Shows Promise

Up Next

Gene Therapy for Wet AMD Shows Promise

More From ASRS: 2024 Coverage